4/11/2011

Sanofi-Aventis finalized a deal worth about $20.1 billion to take over Genzyme. The acquisition, which gives Sanofi access to Genzyme's orphan-drug business, will be partly funded through a $7 billion note offering.

Full Story:
Reuters

Related Summaries